Results 171 to 180 of about 2,627 (188)

The pharmacokinetics and tissue distribution of the glucosylceramide synthase inhibitor miglustat in the rat

Xenobiotica, 2007
A Treiber, M Clozel
exaly  

Miglustat

Reactions Weekly, 2014
openaire   +1 more source

Treatment of NPC with miglustat in Germany

Neuropediatrics, 2008
E Mengel, A Das, F Ebinger, R Hartung, S Koch, C Korenke, T Marquardt, F Rutsch, K Tsiakas   +8 more
openaire   +1 more source

A double-blind, randomized, placebo-controlled trial studying the effects of Saccharomyces boulardii on the gastrointestinal tolerability, safety, and pharmacokinetics of miglustat

Orphanet Journal of Rare Diseases, 2015
Thorsten Marquardt
exaly  

Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C.

Journal of Neuropathology and Experimental Neurology, 2012
Steven U Walkley, Marie T Vanier
exaly  

An open-label, noncomparative study of miglustat in type I Gaucher disease: Efficacy and tolerability over 24 months of treatment

Clinical Therapeutics, 2005
Gregory Pastores, Edwin H Kolodny
exaly  

Influence of Food Intake on the Pharmacokinetics of Miglustat, an Inhibitor of Glucosylceramide Synthase

Journal of Clinical Pharmacology, 2007
Jasper Dingemanse, Paul L M van Giersbergen   +1 more
exaly  

Miglustat.

2011
openaire   +1 more source

Miglustat: profile report

Drugs & Therapy Perspectives, 2004
openaire   +1 more source

Goal-oriented therapy with miglustat in Gaucher disease

Current Medical Research and Opinion, 2009
Atul Mehta, Pilar Giraldo, Gregory Pastores   +2 more
exaly